KAREN PRAHLER: Open Payments
NPI 1578166492 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 15 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $806 · 2025 $625
Food & beverage: $574Education: $51
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $139 |
| ABBVIE INC. | 3 | $126 |
| GENZYME CORPORATION | 1 | $110 |
| Ipsen Biopharmaceuticals, Inc | 1 | $102 |
| Janssen Biotech, Inc. | 2 | $75 |
| PFIZER INC. | 3 | $53 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: REZDIFFRA, DUPIXENT, IQIRVO, LINZESS, TREMFYA, XELJANZ, RINVOQ, VELSIPITY.
Industry payments across MD — which companies pay providers there.
